Burling Wealth Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.8M Buy
13,162
+56
+0.4% +$57.2K 2.31% 13
2026
Q1
$12.1M Sell
13,106
-175
-1% -$177K 1.95% 13
2025
Q4
$14.3M Buy
13,281
+758
+6% +$725K 2.22% 13
2025
Q3
$9.56M Buy
12,523
+2,120
+20% +$1.58M 1.58% 17
2025
Q2
$8.11M Buy
10,403
+1,415
+16% +$1.1M 1.5% 17
2025
Q1
$7.42M Buy
8,988
+820
+10% +$682K 1.56% 16
2024
Q4
$6.31M Buy
+8,168
New +$6.76M 1.29% 16

Other funds holding LLY

Burling Wealth Partners's LLY Position: Q2 2026 in Review

Burling Wealth Partners increased its Eli Lilly (LLY) stake by 0.43% in Q2 2026, buying an estimated $57.2K and bringing the position to 13,162 shares worth $15.8M. The position accounts for 2.31% of the portfolio, ranked #13.

Burling Wealth Partners first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Burling Wealth Partners held 13,162 shares of Eli Lilly worth $15.8M as of Q2 2026.
  • Burling Wealth Partners bought 56 Eli Lilly shares in Q2 2026, an estimated $57.2K.
  • Eli Lilly made up 2.31% of Burling Wealth Partners's portfolio in Q2 2026, its #13 holding.
  • Burling Wealth Partners first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Burling Wealth Partners's 13F filing for Q2 2026, filed 4 Aug 2026.